|
SECTION 1. Section 481.102,
Health and Safety Code, is amended to read as follows:
Sec. 481.102. PENALTY GROUP
1. Penalty Group 1 consists of:
(1) the following opiates,
including their isomers, esters, ethers, salts, and salts of isomers,
esters, and ethers, unless specifically excepted, if the existence of these
isomers, esters, ethers, and salts is possible within the specific chemical
designation:
Alfentanil;
Allylprodine;
Alphacetylmethadol;
Benzethidine;
Betaprodine;
Clonitazene;
Diampromide;
Diethylthiambutene;
Difenoxin not listed in
Penalty Group 3 or 4;
Dimenoxadol;
Dimethylthiambutene;
Dioxaphetyl butyrate;
Dipipanone;
Ethylmethylthiambutene;
Etonitazene;
Etoxeridine;
Furethidine;
Hydroxypethidine;
Ketobemidone;
Levophenacylmorphan;
Meprodine;
Methadol;
Moramide;
Morpheridine;
Noracymethadol;
Norlevorphanol;
Normethadone;
Norpipanone;
Phenadoxone;
Phenampromide;
Phenomorphan;
Phenoperidine;
Piritramide;
Proheptazine;
Properidine;
Propiram;
Sufentanil;
Tilidine; and
Trimeperidine;
(2) the following opium
derivatives, their salts, isomers, and salts of isomers, unless
specifically excepted, if the existence of these salts, isomers, and salts
of isomers is possible within the specific chemical designation:
Acetorphine;
Acetyldihydrocodeine;
Benzylmorphine;
Codeine methylbromide;
Codeine-N-Oxide;
Cyprenorphine;
Desomorphine;
Dihydromorphine;
Drotebanol;
Etorphine, except
hydrochloride salt;
Heroin;
Hydromorphinol;
Methyldesorphine;
Methyldihydromorphine;
Monoacetylmorphine;
Morphine methylbromide;
Morphine methylsulfonate;
Morphine-N-Oxide;
Myrophine;
Nicocodeine;
Nicomorphine;
Normorphine;
Pholcodine; and
Thebacon;
(3) the following
substances, however produced, except those narcotic drugs listed in another
group:
(A) Opium and opiate not
listed in Penalty Group 3 or 4, and a salt, compound, derivative, or
preparation of opium or opiate, other than thebaine derived butorphanol,
nalmefene and its salts, naloxone and its salts, and naltrexone and its salts,
but including:
Codeine not listed in Penalty
Group 3 or 4;
Dihydroetorphine;
Ethylmorphine not listed in
Penalty Group 3 or 4;
Granulated opium;
Hydrocodone not listed in
Penalty Group 3;
Hydromorphone;
Metopon;
Morphine not listed in
Penalty Group 3;
Opium extracts;
Opium fluid extracts;
Oripavine;
Oxycodone;
Oxymorphone;
Powdered opium;
Raw opium;
Thebaine; and
Tincture of opium;
(B) a salt, compound,
isomer, derivative, or preparation of a substance that is chemically
equivalent or identical to a substance described by Paragraph (A), other
than the isoquinoline alkaloids of opium;
(C) Opium poppy and poppy
straw;
(D) Cocaine, including:
(i) its salts, its optical,
position, and geometric isomers, and the salts of those isomers;
(ii) coca leaves and a salt,
compound, derivative, or preparation of coca leaves; and
(iii) a salt, compound,
derivative, or preparation of a salt, compound, or derivative that is
chemically equivalent or identical to a substance described by Subparagraph
(i) or (ii), other than decocainized coca leaves or extractions of coca
leaves that do not contain cocaine or ecgonine; and
(E) concentrate of poppy
straw, meaning the crude extract of poppy straw in liquid, solid, or powder
form that contains the phenanthrine alkaloids of the opium poppy;
(4) the following opiates,
including their isomers, esters, ethers, salts, and salts of isomers, if
the existence of these isomers, esters, ethers, and salts is possible
within the specific chemical designation:
Acetyl-alpha-methylfentanyl
(N-[1-(1-methyl-2- phenethyl)-4-piperidinyl]-N-phenylacetamide);
Alpha-methylthiofentanyl
(N-[1-methyl-2-(2- thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
Alphaprodine;
Anileridine;
Beta-hydroxyfentanyl
(N-[1-(2-hydroxy-2- phenethyl)-4-piperidinyl] -N-phenylpropanamide);
Beta-hydroxy-3-methylfentanyl;
Bezitramide;
Carfentanil;
Dihydrocodeine not listed in
Penalty Group 3 or 4;
Diphenoxylate not listed in
Penalty Group 3 or 4;
Fentanyl or
alpha-methylfentanyl, or any other derivative of Fentanyl;
Isomethadone;
Levomethorphan;
Levorphanol;
Metazocine;
Methadone;
Methadone-Intermediate,
4-cyano-2-dimethylamino- 4, 4-diphenyl butane;
3-methylfentanyl(N-[3-methyl-1-(2-phenylethyl)-
4-piperidyl]-N-phenylpropanamide);
3-methylthiofentanyl(N-[3-methyl-1-(2-thienyl)
ethyl-4-piperidinyl]-N-phenylpropanamide);
Moramide-Intermediate,
2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic acid;
Para-fluorofentanyl(N-(4-fluorophenyl)-N-1-(2-
phenylethyl)-4-piperidinylpropanamide);
PEPAP
(1-(2-phenethyl)-4-phenyl-4- acetoxypiperidine);
Pethidine (Meperidine);
Pethidine-Intermediate-A,
4-cyano-1-methyl-4- phenylpiperidine;
Pethidine-Intermediate-B,
ethyl-4- phenylpiperidine-4 carboxylate;
Pethidine-Intermediate-C,
1-methyl-4- phenylpiperidine-4-carboxylic acid;
Phenazocine;
Piminodine;
Racemethorphan;
Racemorphan;
Remifentanil; and
Thiofentanyl(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);
(5) Flunitrazepam (trade or
other name: Rohypnol);
(6) Methamphetamine,
including its salts, optical isomers, and salts of optical isomers;
(7) Phenylacetone and
methylamine, if possessed together with intent to manufacture
methamphetamine;
(8) Phencyclidine, including
its salts;
(9) Gamma hydroxybutyric
acid (some trade or other names: gamma hydroxybutyrate, GHB), including its
salts; [and]
(10) Ketamine;
(11) U-47700; and
(12) AH-7921.
|
SECTION 1. Section 481.102,
Health and Safety Code, is amended to read as follows:
Sec. 481.102. PENALTY GROUP
1. Penalty Group 1 consists of:
(1) the following opiates,
including their isomers, esters, ethers, salts, and salts of isomers,
esters, and ethers, unless specifically excepted, if the existence of these
isomers, esters, ethers, and salts is possible within the specific chemical
designation:
Alfentanil;
Allylprodine;
Alphacetylmethadol;
Benzethidine;
Betaprodine;
Clonitazene;
Diampromide;
Diethylthiambutene;
Difenoxin not listed in
Penalty Group 3 or 4;
Dimenoxadol;
Dimethylthiambutene;
Dioxaphetyl butyrate;
Dipipanone;
Ethylmethylthiambutene;
Etonitazene;
Etoxeridine;
Furethidine;
Hydroxypethidine;
Ketobemidone;
Levophenacylmorphan;
Meprodine;
Methadol;
Moramide;
Morpheridine;
Noracymethadol;
Norlevorphanol;
Normethadone;
Norpipanone;
Phenadoxone;
Phenampromide;
Phenomorphan;
Phenoperidine;
Piritramide;
Proheptazine;
Properidine;
Propiram;
Sufentanil;
Tilidine; and
Trimeperidine;
(2) the following opium
derivatives, their salts, isomers, and salts of isomers, unless
specifically excepted, if the existence of these salts, isomers, and salts
of isomers is possible within the specific chemical designation:
Acetorphine;
Acetyldihydrocodeine;
Benzylmorphine;
Codeine methylbromide;
Codeine-N-Oxide;
Cyprenorphine;
Desomorphine;
Dihydromorphine;
Drotebanol;
Etorphine, except
hydrochloride salt;
Heroin;
Hydromorphinol;
Methyldesorphine;
Methyldihydromorphine;
Monoacetylmorphine;
Morphine methylbromide;
Morphine methylsulfonate;
Morphine-N-Oxide;
Myrophine;
Nicocodeine;
Nicomorphine;
Normorphine;
Pholcodine; and
Thebacon;
(3) the following
substances, however produced, except those narcotic drugs listed in another
group:
(A) Opium and opiate not
listed in Penalty Group 3 or 4, and a salt, compound, derivative, or
preparation of opium or opiate, other than thebaine derived butorphanol,
nalmefene and its salts, naloxone and its salts, and naltrexone and its
salts, but including:
Codeine not listed in Penalty
Group 3 or 4;
Dihydroetorphine;
Ethylmorphine not listed in
Penalty Group 3 or 4;
Granulated opium;
Hydrocodone not listed in
Penalty Group 3;
Hydromorphone;
Metopon;
Morphine not listed in
Penalty Group 3;
Opium extracts;
Opium fluid extracts;
Oripavine;
Oxycodone;
Oxymorphone;
Powdered opium;
Raw opium;
Thebaine; and
Tincture of opium;
(B) a salt, compound,
isomer, derivative, or preparation of a substance that is chemically
equivalent or identical to a substance described by Paragraph (A), other
than the isoquinoline alkaloids of opium;
(C) Opium poppy and poppy
straw;
(D) Cocaine, including:
(i) its salts, its optical,
position, and geometric isomers, and the salts of those isomers;
(ii) coca leaves and a salt,
compound, derivative, or preparation of coca leaves; and
(iii) a salt, compound,
derivative, or preparation of a salt, compound, or derivative that is
chemically equivalent or identical to a substance described by Subparagraph
(i) or (ii), other than decocainized coca leaves or extractions of coca
leaves that do not contain cocaine or ecgonine; and
(E) concentrate of poppy
straw, meaning the crude extract of poppy straw in liquid, solid, or powder
form that contains the phenanthrine alkaloids of the opium poppy;
(4) the following opiates,
including their isomers, esters, ethers, salts, and salts of isomers, if
the existence of these isomers, esters, ethers, and salts is possible
within the specific chemical designation:
Acetyl-alpha-methylfentanyl
(N-[1-(1-methyl-2- phenethyl)-4-piperidinyl]-N-phenylacetamide);
Alpha-methylthiofentanyl
(N-[1-methyl-2-(2- thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
Alphaprodine;
Anileridine;
Beta-hydroxyfentanyl
(N-[1-(2-hydroxy-2- phenethyl)-4-piperidinyl] -N-phenylpropanamide);
Beta-hydroxy-3-methylfentanyl;
Bezitramide;
Carfentanil;
Dihydrocodeine not listed in
Penalty Group 3 or 4;
Diphenoxylate not listed in
Penalty Group 3 or 4;
Fentanyl or
alpha-methylfentanyl, or any other derivative of Fentanyl;
Isomethadone;
Levomethorphan;
Levorphanol;
Metazocine;
Methadone;
Methadone-Intermediate,
4-cyano-2-dimethylamino- 4, 4-diphenyl butane;
3-methylfentanyl(N-[3-methyl-1-(2-phenylethyl)-
4-piperidyl]-N-phenylpropanamide);
3-methylthiofentanyl(N-[3-methyl-1-(2-thienyl)
ethyl-4-piperidinyl]-N-phenylpropanamide);
Moramide-Intermediate,
2-methyl-3-morpholino-1, 1-diphenyl-propane-carboxylic acid;
Para-fluorofentanyl(N-(4-fluorophenyl)-N-1-(2-
phenylethyl)-4-piperidinylpropanamide);
PEPAP
(1-(2-phenethyl)-4-phenyl-4- acetoxypiperidine);
Pethidine (Meperidine);
Pethidine-Intermediate-A,
4-cyano-1-methyl-4- phenylpiperidine;
Pethidine-Intermediate-B,
ethyl-4- phenylpiperidine-4 carboxylate;
Pethidine-Intermediate-C,
1-methyl-4- phenylpiperidine-4-carboxylic acid;
Phenazocine;
Piminodine;
Racemethorphan;
Racemorphan;
Remifentanil; and
Thiofentanyl(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);
(5) Flunitrazepam (trade or
other name: Rohypnol);
(6) Methamphetamine, including
its salts, optical isomers, and salts of optical isomers;
(7) Phenylacetone and
methylamine, if possessed together with intent to manufacture
methamphetamine;
(8) Phencyclidine, including
its salts;
(9) Gamma hydroxybutyric
acid (some trade or other names: gamma hydroxybutyrate, GHB), including its
salts; [and]
(10) Ketamine;
(11) Phenazepam;
(12) U-47700; and
(13) AH-7921.
|
|
SECTION 2. Section
481.104(a), Health and Safety Code, is amended to read as follows:
(a) Penalty Group 3 consists
of:
(1) a material, compound,
mixture, or preparation that contains any quantity of the following
substances having a potential for abuse associated with a stimulant effect
on the central nervous system:
Methylphenidate and its
salts; and
Phenmetrazine and its salts;
(2) a material, compound,
mixture, or preparation that contains any quantity of the following
substances having a potential for abuse associated with a depressant effect
on the central nervous system:
a substance that contains any
quantity of a derivative of barbituric acid, or any salt of a derivative of
barbituric acid not otherwise described by this subsection;
a compound, mixture, or
preparation containing amobarbital, secobarbital, pentobarbital, or any
salt of any of these, and one or more active medicinal ingredients that are
not listed in any penalty group;
a suppository dosage form
containing amobarbital, secobarbital, pentobarbital, or any salt of any of
these drugs, and approved by the United States Food and Drug Administration
for marketing only as a suppository;
Alprazolam;
Amobarbital;
Bromazepam;
Camazepam;
Carisoprodol;
Chlordiazepoxide;
Chlorhexadol;
Clobazam;
Clonazepam;
Clorazepate;
Clotiazepam;
Cloxazolam;
Delorazepam;
Diazepam;
Estazolam;
Ethyl loflazepate;
Etizolam;
Fludiazepam;
Flurazepam;
Glutethimide;
Halazepam;
Haloxzolam;
Ketazolam;
Loprazolam;
Lorazepam;
Lormetazepam;
Lysergic acid, including its
salts, isomers, and salts of isomers;
Lysergic acid amide,
including its salts, isomers, and salts of isomers;
Mebutamate;
Medazepam;
Methyprylon;
Midazolam;
Nimetazepam;
Nitrazepam;
Nordiazepam;
Oxazepam;
Oxazolam;
Pentazocine, its salts,
derivatives, or compounds or mixtures thereof;
Pentobarbital;
Phenazepam;
Pinazepam;
Prazepam;
Quazepam;
Secobarbital;
Sulfondiethylmethane;
Sulfonethylmethane;
Sulfonmethane;
Temazepam;
Tetrazepam;
Tiletamine and zolazepam in
combination, and its salts. (some trade or other names for a
tiletamine-zolazepam combination product: Telazol, for tiletamine:
2-(ethylamino)- 2-(2-thienyl)-cyclohexanone, and for zolazepam: 4-(2-
fluorophenyl)-6, 8-dihydro-1,3,8,-trimethylpyrazolo-[3,4- e](1,4)-d
diazepin-7(1H)-one, flupyrazapon);
Tramadol;
Triazolam;
Zaleplon;
Zolpidem; and
Zopiclone;
(3) Nalorphine;
(4) a material, compound,
mixture, or preparation containing limited quantities of the following
narcotic drugs, or any of their salts:
not more than 1.8 grams of
codeine, or any of its salts, per 100 milliliters or not more than 90
milligrams per dosage unit, with an equal or greater quantity of an
isoquinoline alkaloid of opium;
not more than 1.8 grams of
codeine, or any of its salts, per 100 milliliters or not more than 90
milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
not more than 300 milligrams
of dihydrocodeinone (hydrocodone), or any of its salts, per 100 milliliters
or not more than 15 milligrams per dosage unit, with a fourfold or greater
quantity of an isoquinoline alkaloid of opium;
not more than 300 milligrams
of dihydrocodeinone (hydrocodone), or any of its salts, per 100 milliliters
or not more than 15 milligrams per dosage unit, with one or more active,
nonnarcotic ingredients in recognized therapeutic amounts;
not more than 1.8 grams of
dihydrocodeine, or any of its salts, per 100 milliliters or not more than
90 milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
not more than 300 milligrams
of ethylmorphine, or any of its salts, per 100 milliliters or not more than
15 milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
not more than 500 milligrams
of opium per 100 milliliters or per 100 grams, or not more than 25
milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
not more than 50 milligrams
of morphine, or any of its salts, per 100 milliliters or per 100 grams with
one or more active, nonnarcotic ingredients in recognized therapeutic
amounts; and
not more than 1 milligram of
difenoxin and not less than 25 micrograms of atropine sulfate per dosage
unit;
(5) a material, compound,
mixture, or preparation that contains any quantity of the following
substances:
Barbital;
Chloral betaine;
Chloral hydrate;
Ethchlorvynol;
Ethinamate;
Meprobamate;
Methohexital;
Methylphenobarbital
(Mephobarbital);
Paraldehyde;
Petrichloral; and
Phenobarbital;
(6) Peyote, unless
unharvested and growing in its natural state, meaning all parts of the
plant classified botanically as Lophophora, whether growing or not, the
seeds of the plant, an extract from a part of the plant, and every
compound, manufacture, salt, derivative, mixture, or preparation of the
plant, its seeds, or extracts;
(7) unless listed in another
penalty group, a material, compound, mixture, or preparation that contains
any quantity of the following substances having a stimulant effect on the
central nervous system, including the substance's salts, optical, position,
or geometric isomers, and salts of the substance's isomers, if the
existence of the salts, isomers, and salts of isomers is possible within
the specific chemical designation:
Benzphetamine;
Cathine [(+)-norpseudoephedrine];
Chlorphentermine;
Clortermine;
Diethylpropion;
Fencamfamin;
Fenfluramine;
Fenproporex;
Mazindol;
Mefenorex;
Modafinil;
Pemoline (including
organometallic complexes and their chelates);
Phendimetrazine;
Phentermine;
Pipradrol;
Sibutramine; and
SPA
[(-)-1-dimethylamino-1,2-diphenylethane];
(8) unless specifically
excepted or unless listed in another penalty group, a material, compound,
mixture, or preparation that contains any quantity of the following
substance, including its salts:
Dextropropoxyphene
(Alpha-(+)-4-dimethylamino- 1,2-diphenyl-3-methyl-2-propionoxybutane);
(9) an anabolic steroid,
including any drug or hormonal substance, or any substance that is
chemically or pharmacologically related to testosterone, other than an
estrogen, progestin, dehydroepiandrosterone, or corticosteroid, and
promotes muscle growth, including the following drugs and substances and
any salt, ester, or ether of the following drugs and substances:
Androstanediol;
Androstanedione;
Androstenediol;
Androstenedione;
Bolasterone;
Boldenone;
Calusterone;
Clostebol;
Dehydrochlormethyltestosterone;
Delta-1-dihydrotestosterone;
Dihydrotestosterone
(4-dihydrotestosterone);
Drostanolone;
Ethylestrenol;
Fluoxymesterone;
Formebulone;
Furazabol;
13beta-ethyl-17beta-hydroxygon-4-en-3-one;
4-hydroxytestosterone;
4-hydroxy-19-nortestosterone;
Mestanolone;
Mesterolone;
Methandienone;
Methandriol;
Methenolone;
17alpha-methyl-3beta, 17
beta-dihydroxy-5alpha- androstane;
17alpha-methyl-3alpha, 17
beta-dihydroxy-5alpha- androstane;
17alpha-methyl-3beta,
17beta-dihydroxyandrost-4- ene;
17alpha-methyl-4-hydroxynandrolone;
Methyldienolone;
Methyltestosterone;
Methyltrienolone;
17alpha-methyl-delta-1-dihydrotestosterone;
Mibolerone;
Nandrolone;
Norandrostenediol;
Norandrostenedione;
Norbolethone;
Norclostebol;
Norethandrolone;
Normethandrolone;
Oxandrolone;
Oxymesterone;
Oxymetholone;
Stanozolol;
Stenbolone;
Testolactone;
Testosterone;
Tetrahydrogestrinone; and
Trenbolone; and
(10) Salvia divinorum,
unless unharvested and growing in its natural state, meaning all parts of
that plant, whether growing or not, the seeds of that plant, an extract
from a part of that plant, and every compound, manufacture, salt,
derivative, mixture, or preparation of that plant, its seeds, or extracts,
including Salvinorin A.
|
SECTION 2. Section
481.104(a), Health and Safety Code, is amended to read as follows:
(a) Penalty Group 3 consists
of:
(1) a material, compound,
mixture, or preparation that contains any quantity of the following
substances having a potential for abuse associated with a stimulant effect
on the central nervous system:
Methylphenidate and its
salts; and
Phenmetrazine and its salts;
(2) a material, compound,
mixture, or preparation that contains any quantity of the following
substances having a potential for abuse associated with a depressant effect
on the central nervous system:
a substance that contains any
quantity of a derivative of barbituric acid, or any salt of a derivative of
barbituric acid not otherwise described by this subsection;
a compound, mixture, or
preparation containing amobarbital, secobarbital, pentobarbital, or any
salt of any of these, and one or more active medicinal ingredients that are
not listed in any penalty group;
a suppository dosage form
containing amobarbital, secobarbital, pentobarbital, or any salt of any of
these drugs, and approved by the United States Food and Drug Administration
for marketing only as a suppository;
Alprazolam;
Amobarbital;
Bromazepam;
Camazepam;
Carisoprodol;
Chlordiazepoxide;
Chlorhexadol;
Clobazam;
Clonazepam;
Clorazepate;
Clotiazepam;
Cloxazolam;
Delorazepam;
Diazepam;
Estazolam;
Ethyl loflazepate;
Etizolam;
Fludiazepam;
Flurazepam;
Glutethimide;
Halazepam;
Haloxzolam;
Ketazolam;
Loprazolam;
Lorazepam;
Lormetazepam;
Lysergic acid, including its
salts, isomers, and salts of isomers;
Lysergic acid amide,
including its salts, isomers, and salts of isomers;
Mebutamate;
Medazepam;
Methyprylon;
Midazolam;
Nimetazepam;
Nitrazepam;
Nordiazepam;
Oxazepam;
Oxazolam;
Pentazocine, its salts,
derivatives, or compounds or mixtures thereof;
Pentobarbital;
Pinazepam;
Prazepam;
Quazepam;
Secobarbital;
Sulfondiethylmethane;
Sulfonethylmethane;
Sulfonmethane;
Temazepam;
Tetrazepam;
Tiletamine and zolazepam in
combination, and its salts. (some trade or other names for a
tiletamine-zolazepam combination product: Telazol, for tiletamine:
2-(ethylamino)- 2-(2-thienyl)-cyclohexanone, and for zolazepam: 4-(2-
fluorophenyl)-6, 8-dihydro-1,3,8,-trimethylpyrazolo-[3,4- e](1,4)-d
diazepin-7(1H)-one, flupyrazapon);
Tramadol;
Triazolam;
Zaleplon;
Zolpidem; and
Zopiclone;
(3) Nalorphine;
(4) a material, compound,
mixture, or preparation containing limited quantities of the following
narcotic drugs, or any of their salts:
not more than 1.8 grams of
codeine, or any of its salts, per 100 milliliters or not more than 90
milligrams per dosage unit, with an equal or greater quantity of an
isoquinoline alkaloid of opium;
not more than 1.8 grams of
codeine, or any of its salts, per 100 milliliters or not more than 90
milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
not more than 300 milligrams
of dihydrocodeinone (hydrocodone), or any of its salts, per 100 milliliters
or not more than 15 milligrams per dosage unit, with a fourfold or greater
quantity of an isoquinoline alkaloid of opium;
not more than 300 milligrams
of dihydrocodeinone (hydrocodone), or any of its salts, per 100 milliliters
or not more than 15 milligrams per dosage unit, with one or more active,
nonnarcotic ingredients in recognized therapeutic amounts;
not more than 1.8 grams of
dihydrocodeine, or any of its salts, per 100 milliliters or not more than
90 milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
not more than 300 milligrams
of ethylmorphine, or any of its salts, per 100 milliliters or not more than
15 milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
not more than 500 milligrams
of opium per 100 milliliters or per 100 grams, or not more than 25
milligrams per dosage unit, with one or more active, nonnarcotic
ingredients in recognized therapeutic amounts;
not more than 50 milligrams
of morphine, or any of its salts, per 100 milliliters or per 100 grams with
one or more active, nonnarcotic ingredients in recognized therapeutic
amounts; and
not more than 1 milligram of
difenoxin and not less than 25 micrograms of atropine sulfate per dosage
unit;
(5) a material, compound,
mixture, or preparation that contains any quantity of the following
substances:
Barbital;
Chloral betaine;
Chloral hydrate;
Ethchlorvynol;
Ethinamate;
Meprobamate;
Methohexital;
Methylphenobarbital (Mephobarbital);
Paraldehyde;
Petrichloral; and
Phenobarbital;
(6) Peyote, unless
unharvested and growing in its natural state, meaning all parts of the
plant classified botanically as Lophophora, whether growing or not, the
seeds of the plant, an extract from a part of the plant, and every
compound, manufacture, salt, derivative, mixture, or preparation of the
plant, its seeds, or extracts;
(7) unless listed in another
penalty group, a material, compound, mixture, or preparation that contains
any quantity of the following substances having a stimulant effect on the
central nervous system, including the substance's salts, optical, position,
or geometric isomers, and salts of the substance's isomers, if the
existence of the salts, isomers, and salts of isomers is possible within
the specific chemical designation:
Benzphetamine;
Cathine
[(+)-norpseudoephedrine];
Chlorphentermine;
Clortermine;
Diethylpropion;
Fencamfamin;
Fenfluramine;
Fenproporex;
Mazindol;
Mefenorex;
Modafinil;
Pemoline (including
organometallic complexes and their chelates);
Phendimetrazine;
Phentermine;
Pipradrol;
Sibutramine; and
SPA
[(-)-1-dimethylamino-1,2-diphenylethane];
(8) unless specifically
excepted or unless listed in another penalty group, a material, compound,
mixture, or preparation that contains any quantity of the following
substance, including its salts:
Dextropropoxyphene
(Alpha-(+)-4-dimethylamino- 1,2-diphenyl-3-methyl-2-propionoxybutane);
(9) an anabolic steroid,
including any drug or hormonal substance, or any substance that is
chemically or pharmacologically related to testosterone, other than an
estrogen, progestin, dehydroepiandrosterone, or corticosteroid, and
promotes muscle growth, including the following drugs and substances and
any salt, ester, or ether of the following drugs and substances:
Androstanediol;
Androstanedione;
Androstenediol;
Androstenedione;
Bolasterone;
Boldenone;
Calusterone;
Clostebol;
Dehydrochlormethyltestosterone;
Delta-1-dihydrotestosterone;
Dihydrotestosterone
(4-dihydrotestosterone);
Drostanolone;
Ethylestrenol;
Fluoxymesterone;
Formebulone;
Furazabol;
13beta-ethyl-17beta-hydroxygon-4-en-3-one;
4-hydroxytestosterone;
4-hydroxy-19-nortestosterone;
Mestanolone;
Mesterolone;
Methandienone;
Methandriol;
Methenolone;
17alpha-methyl-3beta, 17
beta-dihydroxy-5alpha- androstane;
17alpha-methyl-3alpha, 17
beta-dihydroxy-5alpha- androstane;
17alpha-methyl-3beta,
17beta-dihydroxyandrost-4- ene;
17alpha-methyl-4-hydroxynandrolone;
Methyldienolone;
Methyltestosterone;
Methyltrienolone;
17alpha-methyl-delta-1-dihydrotestosterone;
Mibolerone;
Nandrolone;
Norandrostenediol;
Norandrostenedione;
Norbolethone;
Norclostebol;
Norethandrolone;
Normethandrolone;
Oxandrolone;
Oxymesterone;
Oxymetholone;
Stanozolol;
Stenbolone;
Testolactone;
Testosterone;
Tetrahydrogestrinone; and
Trenbolone; and
(10) Salvia divinorum,
unless unharvested and growing in its natural state, meaning all parts of
that plant, whether growing or not, the seeds of that plant, an extract
from a part of that plant, and every compound, manufacture, salt,
derivative, mixture, or preparation of that plant, its seeds, or extracts,
including Salvinorin A.
|